miR-137 likely works through the suppression of either the Cdc42-PAK1-MLC or ERK signaling pathway and the proliferation/invasion of colorectal cancer cells by mimicking the effects of Cdc42 knockdown [122,123]. Here, CDC42 is linked to colorectal cancer.